A detailed history of Quest Partners LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 35,723 shares of HRMY stock, worth $1.22 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
35,723
Previous 15,034 137.61%
Holding current value
$1.22 Million
Previous $454 Million 215.03%
% of portfolio
0.13%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$30.0 - $39.95 $620,670 - $826,525
20,689 Added 137.61%
35,723 $1.43 Billion
Q2 2024

Aug 06, 2024

BUY
$28.81 - $33.01 $306,509 - $351,193
10,639 Added 242.07%
15,034 $454 Million
Q1 2024

May 09, 2024

BUY
$29.93 - $35.06 $120,558 - $141,221
4,028 Added 1097.55%
4,395 $148 Million
Q4 2023

Feb 09, 2024

BUY
$19.2 - $33.78 $7,046 - $12,397
367 New
367 $11.9 Million

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.02B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.